Gold Sponsor:  Sanofi

Bronze Sponsor:  Genetics and Genomics Sciences, Icahn School of Med at Mt Sinai

General Sponsor - AstraZeneca

General Sponsor - IBM Research


2015 DREAM Challenges, powered by Sage BionetworksDear Colleague,

We are pleased to update you on DREAM9.5 and DREAM10 Challenges.

 DREAM9.5 started in late 2014 and will continue in 2015. The DREAM10 Challenges have started in June 2015 and will continue through 2015. 

Best performers in the other DREAM9.5 and DREAM10 Challenges will be invited to present at the RECOMB/ISCB Conference on Regulatory and Systems Genomics, with DREAM Challenges (November 15-18, Philadephia, PA) with partial travel expenses covered by the organizers.
 We also worked with high impact journals to ensure that the methodology developed by the Challenges' best performers will be considered for publication under the challenge-assisted peer review format.

The DREAM9.5 Challenges                                                                

1.  DREAM Olfaction Prediction Challenge: Status: CONCLUDED

  • Challenge Focus: Predict behavioral responses to a panel of odors
  • For the final results click here
  • Congratulations to Prof. Yuanfang Guan (University of Michigan) and Prof. Richard Gerkin (ASU) for their top performance in this Challenge!
  • Journal Partner: Nature Neuroscience

2.  Prostate Cancer DREAM Challenge. Status: ONGOING

  • Challenge Focus: Predict survival for prostate cancer patients based on patients’ clinical variables
  • You can still participate in the Challenge. For more information click here
  • Leaderboard 1 and 2 best performers are listed here.
  • Journal Partner: Nature Biotechnology

The DREAM10 Challenges                                                             

1.  DREAM ALS Stratification Prize4Life Challenge: Status: ONGOING

  • Challenge Focus: Predict progression and survival of ALS patients
  • Join the Challenge: click here
  • Journal Partner: Nature Biotechnology

2.  AstraZeneca-Sanger Drug Combination Prediction DREAM Challenge: Launch Target: Summer 2015

  • Challenge Focus: Predict the effect of drug combinations in cancer cell lines
  • Learn more and pre-register for this Challenge: click here
  • Journal Partner: Nature Biotechnology

3.  ICGC-TCGA DREAM Somatic Mutation Calling Tumor Heterogeneity Challenge (SMC-Het): Launch Target: Summer, 2015

  • Challenge Focus: Identify the best subclonal reconstruction algorithms and to identify the conditions that affect their performance
  • Learn more and pre-register for this Challenge: click here
  • Journal Partner: Nature Biotechnology

For a list of recent DREAM publications see http://dreamchallenges.org/2014-publications/

To learn more about DREAM Challenges and Sage Bionetworks please go to: http://dreamchallenges.org/ and http://sagebase.org

Gustavo Stolovitzky, DREAM Founder and Chair
on behalf of the DREAM9.5 and DREAM10 Challenge Organizers